Maxim lowered the firm’s price target on SWK Holdings (SWKH) to $18 from $21 and keeps a Buy rating on the shares. The tangible book value on the stock is down after the company’s sale of its pharma royalty portfolio and the payout of its $4 per share special dividend, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SWKH: